The continued impact of COVID-19 during the Omicron era on immunocompromised individuals in Japan
IC individuals had a high COVID-19 disease burden during the Omicron era. Appropriate preventive measures should be continued for this population.
Authors
- Kazuhiro Tateda (ORCID: https://orcid.org/0000-0002-6200-6163)
- Atsushi Maruyama (ORCID: https://orcid.org/0000-0002-7495-2974)
- Keiji Sugiyama (ORCID: https://orcid.org/0000-0002-8980-4739)
- Toshibumi Taniguchi (ORCID: https://orcid.org/0000-0002-7732-9870)
- Shinichi Kanazu
- Manabu Hoshino (ORCID: https://orcid.org/0000-0002-5531-0706)
- Tomoyuki Homma
- Ryotaro Ide
Institutions
- Toho University (JP)
- Chiba University Hospital (JP)
- AstraZeneca (France) (FR)
- AstraZeneca (Singapore) (SG)
- AstraZeneca (Japan) (JP)
Publication Details
- Journal
- Journal of Infection and Chemotherapy
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1016/j.jiac.2025.102840
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00